Skip to main content
2024 ACRO Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Joe Chang, MD

Professor
MD Anderson Cancer Center Houston

Dr. Chang holds a tenured Texas 4000 Distinguished Professorship and Director of Stereotactic Ablative Radiotherapy at MD Anderson Cancer Center. He is honored as American Society of Radiation Oncology Fellow and recognized with the Best Doctors of America award. He is a Board Director of Intentional Association for the Study of Lung Cancer (IASLC) and voting committee member of NCCN thoracic guidelines. He serves as chair of Clinical Scientific Program of international Particle Therapy Co-Operative Group (PTCOG). He published more than 300 peer-reviewed articles in prestigious journals including Nature, JAMA, Lancet, Journal of Clinical Oncology, Journal of Thoracic Oncology and many others. H is one of the pioneers in the field of stereotactic ablative radiotherapy (SABR), proton therapy and immunotherapy for lung cancer. His research has helped establish the role of SABR, proton therapy, and combined immunotherapy and SABR (I-SABR) in lung cancer.

Disclosure(s): BMS: Grant/Research Support (Ongoing); IBA: Consultant/Advisory Board (Ongoing); Regeneron: Consultant/Advisory Board (Ongoing)

Presentation(s):

Email Joe